Skip to content

The Effect of Meal Composition on Blood Lipids

The Effect of Meal Composition on Blood Lipid Concentrations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02529709
Enrollment
24
Registered
2015-08-20
Start date
2015-10-31
Completion date
2016-04-30
Last updated
2016-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Brief summary

The purpose of this study is to see if a high-protein meal leads to a better postprandial (after a meal) blood lipid profile compared to a high-monounsaturated meal.

Detailed description

The effect of a high-protein diet compared to a high-monounsaturated fat diet on fasting lipids is controversial (1,2), In addition, these studies did not examine the effect of a high-protein compared to a high-monounsaturated meal on postprandial lipid concentrations. Postprandial lipid responses are important to examine since they are associated with heart disease (3,4). In addition, most individuals in Western countries are in a postprandial state for majority of the day. The present study will compare the effect of a high-protein meal versus a high-monounsaturated fat meal on postprandial lipid responses.

Interventions

OTHERHigh-Protein Condition

The participants will be fed a high-protein meal

OTHERHigh-Monounsaturated Fat Condition

The participants will be fed a high-monounsaturated fat meal

Sponsors

Texas Christian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women ages 18-65 years.

Exclusion criteria

* Use of medications or supplements that affect lipid levels, body weight, or blood glucose, * following a weight loss diet, * being a vegan, * smoking, * heavy alcohol use, * pregnancy, * lactation, * severe depression, * eating disorders, * presence of liver, kidney, gastrointestinal, adrenal, or untreated thyroid disease, * diabetes, * lactose intolerance, * documented mal-absorption, or * bowel surgery that affects absorption.

Design outcomes

Primary

MeasureTime frame
Blood lipid concentrations.At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins

Secondary

MeasureTime frame
TNF-αAt 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
C-reactive proteinAt 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
GLP-1At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
IL-6At 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
GlucagonAt 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
GlucoseAt 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
LeptinAt 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins
InsulinAt 0 minute before the meal begins and at 30, 60, 120, and 180 minutes after the meal begins

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026